451 results on '"Bresolin, Nereo"'
Search Results
2. COVID-19-associated Guillain-Barré syndrome in the early pandemic experience in Lombardia (Italy)
3. Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial
4. Correction to: COVID‑19‑associated Guillain‑Barré syndrome in the early pandemic experience in Lombardia (Italy)
5. Cell-penetrating peptide-conjugated Morpholino rescues SMA in a symptomatic preclinical model
6. Clinical and genetic features of a cohort of patients with MFN2-related neuropathy
7. Clinical, neuroradiological and genetic findings in a cohort of patients with multiple Cerebral Cavernous Malformations
8. Posterior reversible encephalopathy syndrome and COVID-19: A series of 6 cases from Lombardy, Italy
9. Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic
10. Safety and efficacy of rt-PA treatment for acute stroke in pseudoxanthoma elasticum: the first report
11. Extracellular vesicles and amyotrophic lateral sclerosis: from misfolded protein vehicles to promising clinical biomarkers
12. Insights into the identification of a molecular signature for amyotrophic lateral sclerosis exploiting integrated microRNA profiling of iPSC-derived motor neurons and exosomes
13. Animal Models of CMT2A: State-of-art and Therapeutic Implications
14. Noncoding RNAs in Duchenne and Becker muscular dystrophies: role in pathogenesis and future prognostic and therapeutic perspectives
15. Current understanding of and emerging treatment options for spinal muscular atrophy with respiratory distress type 1 (SMARD1)
16. The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer’s Disease and Parkinson’s Disease
17. Mental health and coping strategies in families of children and young adults with muscular dystrophies
18. Molecular Approaches for the Treatment of Pompe Disease
19. Neurofascin (NFASC) gene mutation causes autosomal recessive ataxia with demyelinating neuropathy
20. Mitochondrial dysfunction in fibroblasts of Multiple System Atrophy
21. Glucose-free/high-protein diet improves hepatomegaly and exercise intolerance in glycogen storage disease type III mice
22. Advances, Challenges, and Perspectives in Translational Stem Cell Therapy for Amyotrophic Lateral Sclerosis
23. Disease Modeling and Therapeutic Strategies in CMT2A: State of the Art
24. Preconditioning and Cellular Engineering to Increase the Survival of Transplanted Neural Stem Cells for Motor Neuron Disease Therapy
25. R-Loops in Motor Neuron Diseases
26. A case report of late-onset cerebellar ataxia associated with a rare p.R342W TGM6 (SCA35) mutation
27. Hereditary hemorrhagic telangiectasia associated with cortical development malformation due to a start loss mutation in ENG
28. Hyperacute extensive spinal cord infarction and negative spine magnetic resonance imaging: a case report and review of the literature
29. Expanding the clinical spectrum of the mitochondrial mutation A13084T in the ND5 gene
30. Late-onset leukoencephalopathy in a patient with recessive EARS2 mutations
31. Combined RNA interference and gene replacement therapy targeting MFN2 for the treatment of Charcot-Marie-Tooth type 2A
32. Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial
33. Development of Therapeutics for C9ORF72 ALS/FTD-Related Disorders
34. Correction to: COVID‑19‑associated Guillain‑Barré syndrome in the early pandemic experience in Lombardia (Italy)
35. COVID-19-associated Guillain-Barré syndrome in the early pandemic experience in Lombardia (Italy)
36. Clinical Reasoning: A 75-year-old man with parkinsonism, mood depression, and weight loss
37. Reply: DGUOK recessive mutations in patients with CPEO, mitochondrial myopathy, parkinsonism and mtDNA deletions
38. Subclinical Leber’s hereditary optic neuropathy with pediatric acute spinal cord onset: more than meets the eye
39. MicroRNA expression analysis identifies a subset of downregulated miRNAs in ALS motor neuron progenitors
40. New Mutations in NEB Gene Discovered by Targeted Next-Generation Sequencing in Nemaline Myopathy Italian Patients
41. Antisense Morpholino-Based In Vitro Correction of a Pseudoexon-Generating Variant in the SGCB Gene
42. MicroRNAs as serum biomarkers in Becker muscular dystrophy
43. Variants in KIF1A gene in dominant and sporadic forms of hereditary spastic paraparesis
44. Novel Splice-Site Mutation in SMN1 Associated with a very Severe SMA-I Phenotype
45. A Suspected Case of Cerebral Fat Embolism Triggering a Drug-resistant Status Epilepticus in a HbS/β⁺-Thalassaemia Patient
46. Molecular analysis of SMARD1 patient-derived cells demonstrates that nonsense-mediated mRNA decay is impaired
47. Antisense Oligonucleotide Therapy for the Treatment of C9ORF72 ALS/FTD Diseases
48. Abnormal brain temperature in early-onset Parkinsonʼs disease
49. CACNA1S mutation associated with a case of juvenile-onset congenital myopathy
50. Clinical presentation, comorbidities and treatment of GAD antibodies associated stiff person syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.